One report showed that serum adiponectin levels were higher in COPD patients than in control subjects and were associated with weight loss and systemic inflammation as assessed by circulating tumor necrosis factor-α (TNF-α) levels [15]. The gene discussed is ADIPOQ; the disease is chronic obstructive pulmonary disease.